Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Mercer

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|June 1, 1989
Synthesis and tumor uptake of 5-82Br- and 5-131I-labeled 5-halo-1-(2-fluoro-2-deoxy-beta-D-ribofuranosyl)uracilsJ R Mercer, L H Xu, E E Knaus, et al.
The International Journal of Applied Radiation and Isotopes|November 1, 1984
The synthesis of [36Cl]-, [82Br]- and [123I]-labelled 1-(3'-chloro-(bromo and iodo)-3'-deoxy-beta-D-arabinofuranosyl)uracilY W Lee, J R Mercer, E E Knaus, et al.
Nuclear Medicine and Biology|April 8, 2000
Synthesis, radiolabeling, and biodistribution of putative metabolites of iodoazomycin arabinosideH C Lee, P Kumar, A J McEwan, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 31, 2001
Modern trends in radioimmunotherapy of cancer: pretargeting strategies for the treatment of ovarian cancerS A McQuarrie, Z Xiao, G G Miller, et al.
Nuclear Medicine and Biology|March 9, 2000
Effects of methoxyflurane anesthesia on the pharmacokinetics of 125I-IAZA in Sprague-Dawley ratsD Stypinski, L I Wiebe, Y K Tam, et al.
The British Journal of Radiology|March 1, 1986
Tumour uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models. IX. Radiolabelled 1-(2'-fluoro-2'-deoxy-beta-D-ribofuranosyl)uracil and 1-(2'-chloro-2'-deoxy-beta-D-ribofuranosyl)uracilD N Abrams, Y W Lee, J R Mercer, et al.
Radiation Research|December 1, 1992
Radioiodinated 1-(2-fluoro-4-iodo-2,4-dideoxy-beta-L-xylopyranosyl)-2-nitroimidazole: a novel probe for the noninvasive assessment of tumor hypoxiaR H Mannan, J R Mercer, L I Wiebe, et al.
Journal of Biotechnology|February 14, 2002
A three-step strategy for targeting drug carriers to human ovarian carcinoma cells in vitroZ Xiao, S A McQuarrie, M R Suresh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Dosimetry estimations for 123I-IAZA in healthy volunteersD Stypinski, S A McQuarrie, L I Wiebe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1991
Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxiaR H Mannan, V V Somayaji, J Lee, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|June 1, 1989
Synthesis and tumor uptake of 5-82Br- and 5-131I-labeled 5-halo-1-(2-fluoro-2-deoxy-beta-D-ribofuranosyl)uracilsJ R Mercer, L H Xu, E E Knaus, et al.
The International Journal of Applied Radiation and Isotopes|November 1, 1984
The synthesis of [36Cl]-, [82Br]- and [123I]-labelled 1-(3'-chloro-(bromo and iodo)-3'-deoxy-beta-D-arabinofuranosyl)uracilY W Lee, J R Mercer, E E Knaus, et al.
Nuclear Medicine and Biology|April 8, 2000
Synthesis, radiolabeling, and biodistribution of putative metabolites of iodoazomycin arabinosideH C Lee, P Kumar, A J McEwan, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 31, 2001
Modern trends in radioimmunotherapy of cancer: pretargeting strategies for the treatment of ovarian cancerS A McQuarrie, Z Xiao, G G Miller, et al.
Nuclear Medicine and Biology|March 9, 2000
Effects of methoxyflurane anesthesia on the pharmacokinetics of 125I-IAZA in Sprague-Dawley ratsD Stypinski, L I Wiebe, Y K Tam, et al.
The British Journal of Radiology|March 1, 1986
Tumour uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models. IX. Radiolabelled 1-(2'-fluoro-2'-deoxy-beta-D-ribofuranosyl)uracil and 1-(2'-chloro-2'-deoxy-beta-D-ribofuranosyl)uracilD N Abrams, Y W Lee, J R Mercer, et al.
Radiation Research|December 1, 1992
Radioiodinated 1-(2-fluoro-4-iodo-2,4-dideoxy-beta-L-xylopyranosyl)-2-nitroimidazole: a novel probe for the noninvasive assessment of tumor hypoxiaR H Mannan, J R Mercer, L I Wiebe, et al.
Journal of Biotechnology|February 14, 2002
A three-step strategy for targeting drug carriers to human ovarian carcinoma cells in vitroZ Xiao, S A McQuarrie, M R Suresh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Dosimetry estimations for 123I-IAZA in healthy volunteersD Stypinski, S A McQuarrie, L I Wiebe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1991
Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxiaR H Mannan, V V Somayaji, J Lee, et al.
Pageof 4